Hepatitis C
Get the Flash Player to see this player.
In this segment, gastroenterologist Dr. Mark Avila will discuss current treatment options for Hepatitis C with Drs. John, Kathryn and Edward Martin.
Hepatitis C is a chronic viral infection of the liver. It was originally known as Hepatitis non-A/non-B, but we can now identify it in the blood as a distinct serotype, called hepatitis C.
Hepatitis C is a blood borne disease, so it is seen in patients who have had blood transfusions, IV drug users, with skin piercings and tattoos, and occasionally is sexually transmitted. About 80% of patients will develop a chronic infection, and there is no vaccine available at this time since there virus can mutate so rapidly.
Interferon is the drug of choice for hepatitis C. It is an immunomodulator, which alters the immune system so that the body can fight the virus. The patient receives the medicine once a week for about 6 to 12 months. The side effects can be debilitating and include fatigue, anorexia, weight loss, fever, chills, depression and rashes.